(openPR) - Münster (Germany), 10 September 2008. On 1 September, Dr. Franz-Josef Kappenberg joined the team at Münster, Germany, pharma service provider HÄLSA Pharma GmbH. The registered pharmacist is its new qualified person, specializing in consultancy on good manufacturing practice (GMP). HÄLSA, a Diapharm company (www.diapharm.com), advises manufacturers of medicinal products on matters such as setting up quality assurance systems or the preparatory and follow-up work for GMP inspections by the authorities. HÄLSA also undertakes batch release of medicinal products for pharmaceutical companies.
Until August 2008, Kappenberg worked at Roha Arzneimittel GmbH in Bremen as qualified person, pharmacovigilance commissioner and head of quality control. During his professional career, Dr. Franz-Josef Kappenberg has also worked for Georg Geyer GmbH, Ludwigsburg, and Davimed GmbH (now Lichtenheldt GmbH) in Wahlstedt, where he was head of control, head of re registration and head of the research and development department.
Diapharm supports companies in the pharmaceutical and health care product industry in all regulatory, medicinal and pharmaceutical questions associated with medicinal products, medical devices, food supplements, biocides and cosmetics. A team of about 80 employees in Lübeck, Münster and Oldenburg provides, inter alia, strategic advice, management and responsible care for trademarks and product portfolios. Diapharm is present throughout Europe with partners in France, Great Britain, Poland, Portugal, Slovenia, Spain, the Czech Republic and Hungary.
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
Newsfeed
